Dr. Jonathan Robert Thompson, MD

Dr. Thompson practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Thompson's NPI, 1831329689, was assigned on July 14, 2009. Dr. Thompson graduated from University of Wisconsin School of Medicine in 2009. Dr. Thompson holds Nebraska license 26200.

Dr. Thompson's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Thompson also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Thompson's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Thompson is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Thompson to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thompson practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Thompson's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Thompson is licensed in Nebraska.

CMS data shows 1,113 Medicare services from Dr. Thompson across 16 procedure codes in 2024, for 913 Medicare patients. Medicare paid $33,982 for them.

CMS counts 913 Medicare patients who saw Dr. Thompson in 2024. The largest group is 65 to 74, with 415 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thompson's median patient age at 73, with 42% women.

In 2024, Dr. Thompson wrote 458 Medicare Part D claims for 98 patients. 83% of them were for generic drugs. CMS names the drug for 433 of them, across 9 drugs with 11 or more claims each, at $50,829 in total drug cost. In 2023, CMS named 310 claims across 8 drugs.

Dr. Thompson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thompson as offering telehealth. CMS counts 18 procedures of leg revascularization (restoring blood flow) by Dr. Thompson, more than 77% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Thompson, published from 2013 to 2025. 2013 was the busiest year, with 3. The most frequent topics are Peripheral Arterial Disease, Muscle, Skeletal and Intermittent Claudication. Dr. Thompson has published most often in J Vasc Surg. Dr. Thompson's most frequent co-authors are Iraklis I. Pipinos, MD, Jason M. Johanning, MD and Dimitrios Miserlis, MD.

Dmand AI links Dr. Thompson to 6 clinical trials, 3 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Adenocarcinoma of Lung. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 67 general payments to Dr. Thompson from 10 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 52% of the total. W. L. Gore & Associates, Inc. paid the most, $2,813.

Dr. Thompson graduated from University of Wisconsin School of Medicine in 2009.